miR-133a targets YES1 to reduce cisplatin resistance in ovarian cancer by regulating cell autophagy

BACKGROUND: Accumulating evidence has revealed that aberrant microRNA (miRNA) expression can affect the development of chemotherapy drug resistance by modulating the expression of relevant target proteins. Emerging evidence has demonstrated that miR-133a participates in the tumorigenesis of various...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yang, Wang, Chunyan, Ding, Jinye, Chen, Yingying, Sun, Yaoqi, Cheng, Zhongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751326/
https://www.ncbi.nlm.nih.gov/pubmed/35012539
http://dx.doi.org/10.1186/s12935-021-02412-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751326/
https://www.ncbi.nlm.nih.gov/pubmed/35012539
http://dx.doi.org/10.1186/s12935-021-02412-x

Ejemplares similares